Cargando…
培美曲塞联合顺铂或卡铂治疗复发或转移性非小细胞肺癌63例疗效分析
BACKGROUND AND OBJECTIVE: Since the poor outcome for advanced lung cancer with frst-line chemotherapy, more efforts should be paid for treatment of advanced recurrent or metastasis non-small cell lung cancer (NSCLC) patients. Pemetrexed, as a multi-target antifolate chemotherapeutic drug, was approv...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999704/ https://www.ncbi.nlm.nih.gov/pubmed/21219833 http://dx.doi.org/10.3779/j.issn.1009-3419.2011.01.11 |
Ejemplares similares
-
培美曲塞联合顺铂对比吉西他滨联合顺铂一线治疗晚期非鳞非小细胞肺癌的随机、对照、多中心临床研究
Publicado: (2012) -
培美曲塞单药或联合铂类三线及以上治疗晚期非鳞型非小细胞肺癌的临床观察
Publicado: (2012) -
培美曲塞联合铂类对比吉西他滨联合铂类治疗晚期非小细胞肺癌的meta分析
Publicado: (2011) -
培美曲塞/顺铂二线治疗晚期非小细胞肺癌:一例报告及文献复习
Publicado: (2010) -
伊立替康联合奈达铂对比联合顺铂二线治疗复发或难治性小细胞肺癌的疗效及毒副作用回顾分析
Publicado: (2013)